Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life
Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the defective synthesis of collagen and elastin due t...
Main Authors: | Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach, Evgeny D. Dolgov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2022-11-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/110734/pdf |
Similar Items
-
Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review
by: Mekan R. Orazov, et al.
Published: (2023-01-01) -
Effectiveness of alternative GSM therapies: "twist of fate" or natural evolution?
by: Mekan R. Orazov, et al.
Published: (2022-09-01) -
Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
by: Andrew T. Goldstein, MD, et al.
Published: (2016-09-01) -
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats
by: Nur Hilwani Ismail, et al.
Published: (2023-02-01) -
Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018
by: A. D. Makatsariya, et al.
Published: (2019-09-01)